Capstone Financial Advisors’s UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share UPH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,000
Closed -$198 160
2023
Q3
$198 Hold
20,000
﹤0.01% 145
2023
Q2
$398 Hold
20,000
﹤0.01% 146
2023
Q1
$400 Hold
20,000
﹤0.01% 140
2022
Q4
$260 Hold
20,000
﹤0.01% 140
2022
Q3
$1K Hold
20,000
﹤0.01% 140
2022
Q2
$1K Hold
20,000
﹤0.01% 141
2022
Q1
$4K Buy
+20,000
New +$6.16K ﹤0.01% 143

Other funds holding UPH.WS

Capstone Financial Advisors's UPH.WS Position: Q4 2023 in Review

Capstone Financial Advisors sold out of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) in Q4 2023, closing a stake of 20,000 shares — an estimated $198 sold.

Capstone Financial Advisors first reported a position in UPH.WS in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 1 fund tracked by Wall St. Rank holds UPH.WS as of Q4 2023.

  • Capstone Financial Advisors reported no remaining UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position as of Q4 2023 after selling out during the quarter.
  • Capstone Financial Advisors sold 20,000 UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share shares in Q4 2023, an estimated $198.
  • Capstone Financial Advisors first reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in Q1 2022 and held it in 7 quarters.
  • Capstone Financial Advisors's UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position peaked at $4K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share as of Q4 2023.

Based on Capstone Financial Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.